Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Agra Ventures Announces Results of its Annual General & Special Meeting By: Agra Ventures Ltd. via GlobeNewswire July 21, 2023 at 17:30 PM EDT VANCOUVER, British Columbia, July 21, 2023 (GLOBE NEWSWIRE) -- Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTCPK: AGFAF), a company focused on the cannabis industry, is pleased to provide the voting results from its Annual General & Special Meeting ("AGSM") that was held today in Vancouver, British Columbia. A total of 43,331,793 common shares of the Company were voted, representing 27.09% of AGRA’s outstanding shares. Shareholders voted in favour of all applicable items of business set before the meeting, as follows: Percentage of Votes CastNumber of Directors% For% AgainstNumber of Directors to be set at four (4)96.74%3.26%Election of directors% For% of Votes WithheldNick Kuzyk91.84%8.16%Fiona Fitzmaurice91.17%8.83%Anthony Carnevale90.99%9.01%Jonathan Hirsh91.31%8.69%Appointment of Auditor% For% of Votes WithheldTo appoint Baker Tilly LLP, Chartered Accountants as auditor of the Company for the ensuing year and to authorize the directors to fix their remuneration.88.33%11.67%Approval of Stock Option Plan% For% AgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of shareholders approving the Company’s stock option plan as more particularly described in the accompanying Information Circular dated June 16, 2023 (the “Information Circular”).87.70%12.30%Approve Restricted Share Unit Plan% For% AgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of shareholders approving the Company’s restricted share unit plan, as more particularly described in the accompanying Information Circular.87.88%12.12%Approval of consolidationForAgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of Shareholders approving the consolidation of the Company’s issued and outstanding common shares (the “Common Shares”) on the basis of one (1) new post-consolidation Common Share for every twenty-five (25) currently outstanding Common Shares, as more particularly described in the accompanying Information Circular.72.75%27.25% Nick Kuzyk, Fiona Fitzmaurice, Anthony Carnevale, and Jonathan Hirsh were all re-elected to the Board of Directors at the AGSM. Share Consolidation On May 30, 2023 and June 2, 2023, the Company announced a proposed share consolidation (the “Share Consolidation”) whereby Shareholders will receive one (1) post-consolidation voting common share for up to twenty-five (25) pre-consolidation voting common shares held by them. As the Company has now received the requisite shareholder approval, it will be proceeding with the Share Consolidation. Details including the new CUSIP/ISIN numbers and effective date will be announced in an upcoming news release. About Agra Ventures Ltd. Agra Ventures is a company focused on the cannabis industry. The company’s wholly owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis as well as its proprietary CBD and THC test kits. Farmako currently has active product distribution operations in Germany and is fully licensed in the United Kingdom. For more information about Agra Ventures, please visit www.agraventures.com and its profile page on SEDAR at www.sedar.com. ON BEHALF OF THE BOARD OF DIRECTORS Nick Kuzyk, CEO & DirectorE: ir@agraventures.com T: (800) 783-6056 The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release. Forward-looking Information Cautionary Statement Except for statements of historic fact this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan” “expect” “project” “intend” “believe” “anticipate” “estimate” and other similar words or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including but not limited to delays or uncertainties with regulatory approvals including that of the CSE. There are uncertainties inherent in forward-looking information including factors beyond the Company’s control. There are no assurances that the business plans for Agra Ventures described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators which are available at www.sedar.com. SOURCE: Agra Ventures Ltd. Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Agra Ventures Announces Results of its Annual General & Special Meeting By: Agra Ventures Ltd. via GlobeNewswire July 21, 2023 at 17:30 PM EDT VANCOUVER, British Columbia, July 21, 2023 (GLOBE NEWSWIRE) -- Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTCPK: AGFAF), a company focused on the cannabis industry, is pleased to provide the voting results from its Annual General & Special Meeting ("AGSM") that was held today in Vancouver, British Columbia. A total of 43,331,793 common shares of the Company were voted, representing 27.09% of AGRA’s outstanding shares. Shareholders voted in favour of all applicable items of business set before the meeting, as follows: Percentage of Votes CastNumber of Directors% For% AgainstNumber of Directors to be set at four (4)96.74%3.26%Election of directors% For% of Votes WithheldNick Kuzyk91.84%8.16%Fiona Fitzmaurice91.17%8.83%Anthony Carnevale90.99%9.01%Jonathan Hirsh91.31%8.69%Appointment of Auditor% For% of Votes WithheldTo appoint Baker Tilly LLP, Chartered Accountants as auditor of the Company for the ensuing year and to authorize the directors to fix their remuneration.88.33%11.67%Approval of Stock Option Plan% For% AgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of shareholders approving the Company’s stock option plan as more particularly described in the accompanying Information Circular dated June 16, 2023 (the “Information Circular”).87.70%12.30%Approve Restricted Share Unit Plan% For% AgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of shareholders approving the Company’s restricted share unit plan, as more particularly described in the accompanying Information Circular.87.88%12.12%Approval of consolidationForAgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of Shareholders approving the consolidation of the Company’s issued and outstanding common shares (the “Common Shares”) on the basis of one (1) new post-consolidation Common Share for every twenty-five (25) currently outstanding Common Shares, as more particularly described in the accompanying Information Circular.72.75%27.25% Nick Kuzyk, Fiona Fitzmaurice, Anthony Carnevale, and Jonathan Hirsh were all re-elected to the Board of Directors at the AGSM. Share Consolidation On May 30, 2023 and June 2, 2023, the Company announced a proposed share consolidation (the “Share Consolidation”) whereby Shareholders will receive one (1) post-consolidation voting common share for up to twenty-five (25) pre-consolidation voting common shares held by them. As the Company has now received the requisite shareholder approval, it will be proceeding with the Share Consolidation. Details including the new CUSIP/ISIN numbers and effective date will be announced in an upcoming news release. About Agra Ventures Ltd. Agra Ventures is a company focused on the cannabis industry. The company’s wholly owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis as well as its proprietary CBD and THC test kits. Farmako currently has active product distribution operations in Germany and is fully licensed in the United Kingdom. For more information about Agra Ventures, please visit www.agraventures.com and its profile page on SEDAR at www.sedar.com. ON BEHALF OF THE BOARD OF DIRECTORS Nick Kuzyk, CEO & DirectorE: ir@agraventures.com T: (800) 783-6056 The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release. Forward-looking Information Cautionary Statement Except for statements of historic fact this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan” “expect” “project” “intend” “believe” “anticipate” “estimate” and other similar words or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including but not limited to delays or uncertainties with regulatory approvals including that of the CSE. There are uncertainties inherent in forward-looking information including factors beyond the Company’s control. There are no assurances that the business plans for Agra Ventures described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators which are available at www.sedar.com. SOURCE: Agra Ventures Ltd.
VANCOUVER, British Columbia, July 21, 2023 (GLOBE NEWSWIRE) -- Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTCPK: AGFAF), a company focused on the cannabis industry, is pleased to provide the voting results from its Annual General & Special Meeting ("AGSM") that was held today in Vancouver, British Columbia. A total of 43,331,793 common shares of the Company were voted, representing 27.09% of AGRA’s outstanding shares. Shareholders voted in favour of all applicable items of business set before the meeting, as follows: Percentage of Votes CastNumber of Directors% For% AgainstNumber of Directors to be set at four (4)96.74%3.26%Election of directors% For% of Votes WithheldNick Kuzyk91.84%8.16%Fiona Fitzmaurice91.17%8.83%Anthony Carnevale90.99%9.01%Jonathan Hirsh91.31%8.69%Appointment of Auditor% For% of Votes WithheldTo appoint Baker Tilly LLP, Chartered Accountants as auditor of the Company for the ensuing year and to authorize the directors to fix their remuneration.88.33%11.67%Approval of Stock Option Plan% For% AgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of shareholders approving the Company’s stock option plan as more particularly described in the accompanying Information Circular dated June 16, 2023 (the “Information Circular”).87.70%12.30%Approve Restricted Share Unit Plan% For% AgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of shareholders approving the Company’s restricted share unit plan, as more particularly described in the accompanying Information Circular.87.88%12.12%Approval of consolidationForAgainstTo consider and, if deemed appropriate, to pass an ordinary resolution of Shareholders approving the consolidation of the Company’s issued and outstanding common shares (the “Common Shares”) on the basis of one (1) new post-consolidation Common Share for every twenty-five (25) currently outstanding Common Shares, as more particularly described in the accompanying Information Circular.72.75%27.25% Nick Kuzyk, Fiona Fitzmaurice, Anthony Carnevale, and Jonathan Hirsh were all re-elected to the Board of Directors at the AGSM. Share Consolidation On May 30, 2023 and June 2, 2023, the Company announced a proposed share consolidation (the “Share Consolidation”) whereby Shareholders will receive one (1) post-consolidation voting common share for up to twenty-five (25) pre-consolidation voting common shares held by them. As the Company has now received the requisite shareholder approval, it will be proceeding with the Share Consolidation. Details including the new CUSIP/ISIN numbers and effective date will be announced in an upcoming news release. About Agra Ventures Ltd. Agra Ventures is a company focused on the cannabis industry. The company’s wholly owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis as well as its proprietary CBD and THC test kits. Farmako currently has active product distribution operations in Germany and is fully licensed in the United Kingdom. For more information about Agra Ventures, please visit www.agraventures.com and its profile page on SEDAR at www.sedar.com. ON BEHALF OF THE BOARD OF DIRECTORS Nick Kuzyk, CEO & DirectorE: ir@agraventures.com T: (800) 783-6056 The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release. Forward-looking Information Cautionary Statement Except for statements of historic fact this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan” “expect” “project” “intend” “believe” “anticipate” “estimate” and other similar words or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including but not limited to delays or uncertainties with regulatory approvals including that of the CSE. There are uncertainties inherent in forward-looking information including factors beyond the Company’s control. There are no assurances that the business plans for Agra Ventures described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators which are available at www.sedar.com. SOURCE: Agra Ventures Ltd.